Merus N.V. (MRUS) Financials
MRUS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 458.5 million | 102.2 million |
| 2023-09-30 | 492.2 million | 98.8 million |
| 2023-06-30 | 363.6 million | 106.2 million |
| 2023-03-31 | 338.5 million | 121.0 million |
MRUS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -34.8 million | 6.7 million |
| 2023-09-30 | -27.6 million | 7.3 million |
| 2023-06-30 | -41.9 million | 6.5 million |
| 2023-03-31 | -40.4 million | 5.8 million |
MRUS Net Income
No data available :(
MRUS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 355.2 million | - | 12.2 million |
| 2023-09-30 | 388.6 million | - | 12.1 million |
| 2023-06-30 | 265.0 million | - | 12.8 million |
| 2023-03-31 | 241.2 million | - | 13.2 million |
MRUS Shares Outstanding
MRUS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 73937 | 40.7 million | 15.8 million | 618000 |
| 2023-09-30 | 39000 | 36.8 million | 12.6 million | - |
| 2023-06-30 | 349000 | 28.3 million | 16.1 million | - |
| 2023-03-31 | 3.6 million | 34.9 million | 15.4 million | - |
MRUS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 8.9 million | - |
| 2023-09-30 | 11.0 million | 34.8 million |
| 2023-06-30 | 10.5 million | 25.9 million |
| 2023-03-31 | 13.5 million | 32.1 million |
MRUS
Price: $45.11
52 week price:
Earnings Per Share: -3.00 USD
P/E Ratio: -10.23
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 272700
Ebitda: -11.8 millionMarket Capitalization: 2.6 billion